TCDA
Closed
Tricida Inc
0.0141
+0.0011 (+8.46%)
Last Update: 27 Mar 2023 16:30:00
Yesterday: 0.013
Day's Range: 0.013 - 0.0141
Send
sign up or login to leave a comment!
When Written:
0.0141
Tricida Inc is a pharmaceutical company that develops and commercializes therapies for patients with chronic kidney disease. The company's lead product candidate, TRC101, is a non-absorbed polymer that is designed to treat metabolic acidosis, a common complication of chronic kidney disease. Tricida's mission is to improve the lives of patients with chronic kidney disease by developing innovative therapies that address unmet medical needs. The company was founded in 2013 and is headquartered in South San Francisco, California. Tricida went public in 2018 and is traded on the NASDAQ under the ticker symbol TCDA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








